Model
Video GP consultations, regionally integrated in Sweden with a private tier. Whether GLP-1 prescribing is a core offering rather than an adjacent one is unconfirmed.
Funding
$300–316m raised April 2021 at roughly $2bn valuation; a $160m Series D follow-on in July 2022.
Scale
Reported profitable across all markets by early 2024.
Regulatory history
Withdrew from Germany and cut about 10% of workforce in October 2022, a notable prior market exit.
In 2026
Livi partnered with Klarna to offer digital healthcare consultations, June 2026.
Markets
Sweden, Norway, France, United Kingdom.
00
Sources on the summary above
Kry profitable across all marketssecondary
Livi partners with Klarnasecondary